Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine drops for recalcitrant oral lesions in pemphigus vulgaris
IRCT20221002056070N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in pemphigus vulgaris (PV) comparing Pilocarpine 4% drop with Placebo (2 arms). Primary endpoints: Oral Disease Severity Score, Visual analogue scale and 2 more. Started Feb 2024; status: completed.
02
Drugs
pilocarpine
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on IRCT20221002056070N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221002056070N1.